Table 4.
OR (CI 95%) | p | |
---|---|---|
Age | 1.01 (0.98–1.02) | 0.623 |
Gender (F) | 2.31 (1.44–3.70) | 0.001 |
AHI severity | 0.366 | |
Mild vs moderate/severe | 0.70 (0.41–1.19) | 0.188 |
Moderate vs mild/severe | 0.75 (0.43–1.32) | 0.322 |
ESS ≥ 10 | 2.24 (1.38–3.63) | 0.001 |
GERD-Q ≥ 8 | 2.75 (1.70–4.45) | < 0.001 |
N comorbidities | 0.99 (0.83–1.20) | 0.985 |
N symptoms | 1.25 (1.08–1.45) | 0.002 |
Anxiety/Depression | 1.89 (1.17–3.06) | 0.009 |
Diabetes mellitus | 1.89 (0.93–3.82) | 0.078 |
Thyroid diseases | 0.84 (0.44–1.62) | 0.601 |
Hiatal hernia | 0.94 (0.48–1.82) | 0.848 |
Gastric ulcer/Gastritis | 1.67 (0.92–3.05) | 0.093 |
Rhinitis/Rhinosinusitis | 1.16 (0.58–2.35) | 0.675 |
Neurological diseasesa | 1.52 (0.67–3.48) | 0.321 |
aOther than neurological diseases used as exclusion criteria
Significant associations are reported in bold. Data are reported as OR (CI 95%). The model correctly classified 87% of the patients
F, female; AHI, apnea–hypopnea index; ESS, Epworth Sleepiness Scale